Distal deletion 17q syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1597Q93.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Distal deletion 17q syndrome (also known as distal monosomy 17q or terminal deletion 17q) is a rare chromosomal disorder caused by a partial deletion of the long arm (q arm) of chromosome 17, specifically involving the distal (terminal) region. This condition is characterized by a variable clinical presentation depending on the size and exact location of the deleted segment. The syndrome affects multiple body systems, including the central nervous system, musculoskeletal system, and craniofacial structures. Key clinical features commonly reported include intellectual disability of variable severity, developmental delay, growth retardation, microcephaly, and distinctive craniofacial dysmorphisms such as a broad forehead, flat nasal bridge, thin upper lip, and low-set ears. Limb anomalies, cardiac malformations, and genitourinary abnormalities may also be present. Hypotonia is frequently observed in infancy. Some patients may exhibit seizures and behavioral difficulties. There is no specific cure for distal deletion 17q syndrome. Management is supportive and symptomatic, tailored to the individual's clinical manifestations. This may include early intervention programs, speech and occupational therapy, physical therapy, and specialized educational support. Cardiac or orthopedic anomalies may require surgical intervention. Regular follow-up with a multidisciplinary team including geneticists, neurologists, cardiologists, and developmental specialists is recommended to optimize outcomes and quality of life.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormality of the philtrumHP:0000288Deviation of fingerHP:0004097
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Distal deletion 17q syndrome.

View clinical trials →

No actively recruiting trials found for Distal deletion 17q syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Distal deletion 17q syndrome community →

No specialists are currently listed for Distal deletion 17q syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Distal deletion 17q syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Distal deletion 17q syndromeForum →

No community posts yet. Be the first to share your experience with Distal deletion 17q syndrome.

Start the conversation →

Latest news about Distal deletion 17q syndrome

No recent news articles for Distal deletion 17q syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Distal deletion 17q syndrome

What is Distal deletion 17q syndrome?

Distal deletion 17q syndrome (also known as distal monosomy 17q or terminal deletion 17q) is a rare chromosomal disorder caused by a partial deletion of the long arm (q arm) of chromosome 17, specifically involving the distal (terminal) region. This condition is characterized by a variable clinical presentation depending on the size and exact location of the deleted segment. The syndrome affects multiple body systems, including the central nervous system, musculoskeletal system, and craniofacial structures. Key clinical features commonly reported include intellectual disability of variable se

How is Distal deletion 17q syndrome inherited?

Distal deletion 17q syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Distal deletion 17q syndrome typically begin?

Typical onset of Distal deletion 17q syndrome is neonatal. Age of onset can vary across affected individuals.